2 months Edwards Lifesciences (NYSE:EW) Given New $78.00 Price Target at JPMorgan Chase & Co. MarketBeat
JPMorgan Chase & Co. lifted their target price on shares of Edwards Lifesciences from $72.00 to $78.00 and gave the company a “neutral” rating in a report on Friday.
Edwards Lifesciences (EW) · JPMorgan (JPM) · NYSE
X